Feasibility Study Of An IL-2 Expressing, Attenuated Salmonella Typhimurium In Patients With Resectable Hepatic Primary Tumor or Hepatic Spread From Any Non-Hematologic Primary
|Effective start/end date||8/1/13 → 6/30/14|
- Courante Oncology, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.